GBT Guerbet SA

GUERBET : Financial agenda for 2026

GUERBET : Financial agenda for 2026

Financial agenda for 2026

Villepinte, November 19, 2025: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2026.

Publications calendar
  • 2025 ANNUAL REVENUE
February 05, 2026, after trading
  • 2025 ANNUAL RESULTS
March 11, 2026, after trading
  • 2026 1ST QUARTER REVENUE
April 23, 2026, after trading
  • ANNUAL SHAREHOLDERS’ MEETING
May 22, 2026
  • 2026 2ND QUARTER REVENUE
July 23, 2026, after trading
  • 2026 FIRST HALF RESULTS
September 15, 2026, after trading
  • 2026 3RD QUARTER REVENUE
October 22, 2026, after trading

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. As pioneers in contrast products for 98 years, with more than 2,905 employees worldwide, we continuously innovate and devote 9% of our revenue to Research and Development in four centers in France and the United States. Guerbet (GBT) is listed in compartment B of Euronext Paris and generated revenue of €841m in 2024. For more information, please visit .



Contacts:

Guerbet     

Christine Allard, SVP Public Affairs and Corporate Communications 82 /

Seitosei.Actifin                                                                                       

Marianne Py, Financial Communication 93 /

Anne-Claire Taton, Press 18 /

Attachment



EN
19/11/2025

Underlying

GBTGuerbet SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Guerbet SA

 PRESS RELEASE
Free
GBT GUERBET SA

Guerbet: Appointment of Mr. François Convenant as Senior Vice Presiden...

Guerbet: Appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Guerbet announces the appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Villepinte, December 19, 2025: GUERBET (FR0000032526 GBT), a global player in medical imaging, announces the appointment of François Convenant as Senior Vice President of Interventional Radiology.In this role, he joins the Guerbet Group's Executive Committee (COMEX). This appointment marks an...

16m 1 EN
 PRESS RELEASE
Free
GBT GUERBET SA

GUERBET: Nomination de M. François Convenant en tant que Senior Vice-P...

GUERBET: Nomination de M. François Convenant en tant que Senior Vice-Président Radiologie Interventionnelle et son entrée au Comité Exécutif Guerbet annonce la nomination de M. François Convenant en tant que Senior Vice-Président Radiologie Interventionnelle et son entrée au Comité Exécutif   Villepinte, le 19 décembre 2025 : GUERBET (FR0000032526 GBT), acteur mondial de l’imagerie médicale, annonce la nomination de François Convenant au poste de Senior Vice-Président Radiologie Interventionnelle. À ce titre, il rejoint le Comité Exécutif (COMEX) du groupe Guerbet. Cette nomination mar...

16m 1 EN
Elias New ... (+2)
  • Elias New
  • Philip Hettich
GBF BILFINGER SE
GBT GUERBET SA
CDA COMPAGNIE DES ALPES SA
BOSS HUGO BOSS AG
A1XA4J CARBIOS SA
QDT QUADIENT SA
CAI CA IMMOBILIEN ANLAGEN AG
UBS UBM DEVELOPMENT AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
COPN COSMO PHARMACEUTICALS NV
M MED LIFE
WAVE WAVESTONE SA
LOUP SOCIETE L.D.C.
SHA SCHAEFFLER AG
12/03/25 December 3, 2025 1 EN
Elias New ... (+2)
  • Elias New
  • Philip Hettich
GBF BILFINGER SE
GBT GUERBET SA
CDA COMPAGNIE DES ALPES SA
BOSS HUGO BOSS AG
A1XA4J CARBIOS SA
QDT QUADIENT SA
CAI CA IMMOBILIEN ANLAGEN AG
UBS UBM DEVELOPMENT AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
COPN COSMO PHARMACEUTICALS NV
M MED LIFE
WAVE WAVESTONE SA
LOUP SOCIETE L.D.C.
SHA SCHAEFFLER AG
12/03/25 December 3, 2025 1 FR
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
12/03/25 December 3, 2025 1 FR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch